AIM: To investigate the differences in the secretion of NT-proBNP and conventional cardiac markers in patients with STE-ACS vs. NSTE-ACS as a trial to solve the dilemma of the early detection of myocardial ischemia in NSTE-ACS. DESIGN: prospective case control hospital based study. SETTING: King Fahad Specialist Hospital, Buraidah, Kingdom of Saudi Arabia. PATIENTS AND METHODS: Sixty two patients with acute coronary syndrome (ACS) were divided into 2 groups according to ECG: group1 with elevated ST segment in ECG ( STE-ACS) and group 2 with non elevated ST segment (NSTE-ACS). Twenty healthy subjects with matched age and sex were enrolled as control group in this study. In the sera of all subjects, levels of NT -proBNP, CK-MB and troponin- T were measured by different kits. RESULTS: CK-MB and Tn-T were both significantly higher in STE-ACS patients as compared to NSTE-ACS patients. Conversely, NT-proBNP was significantly higher in NSTE-ACS patients than STE-ACS especially within 4 hours from onset of chest pain. This suggested a larger ischemic insult despite the smaller extent of myocardial necrosis compared with STE-ACS patients. Comparison between sensitivity and specificity of NT-proBNP, Tn-T and CK-MB levels by ROC curves revealed a marked difference of area under the curves with higher sensitivity and specificity of NT-proBNP in NSTE-ACS patients. CONCLUSIONS: NT-proBNP can serve as a sensitive marker in the early phase of NSTE-ACS patients as compared to conventional markers of myocardial damage.
AIM: To investigate the differences in the secretion of NT-proBNP and conventional cardiac markers in patients with STE-ACS vs. NSTE-ACS as a trial to solve the dilemma of the early detection of myocardial ischemia in NSTE-ACS. DESIGN: prospective case control hospital based study. SETTING: King Fahad Specialist Hospital, Buraidah, Kingdom of Saudi Arabia. PATIENTS AND METHODS: Sixty two patients with acute coronary syndrome (ACS) were divided into 2 groups according to ECG: group1 with elevated ST segment in ECG ( STE-ACS) and group 2 with non elevated ST segment (NSTE-ACS). Twenty healthy subjects with matched age and sex were enrolled as control group in this study. In the sera of all subjects, levels of NT -proBNP, CK-MB and troponin- T were measured by different kits. RESULTS: CK-MB and Tn-T were both significantly higher in STE-ACS patients as compared to NSTE-ACS patients. Conversely, NT-proBNP was significantly higher in NSTE-ACS patients than STE-ACS especially within 4 hours from onset of chest pain. This suggested a larger ischemic insult despite the smaller extent of myocardial necrosis compared with STE-ACS patients. Comparison between sensitivity and specificity of NT-proBNP, Tn-T and CK-MB levels by ROC curves revealed a marked difference of area under the curves with higher sensitivity and specificity of NT-proBNP in NSTE-ACS patients. CONCLUSIONS: NT-proBNP can serve as a sensitive marker in the early phase of NSTE-ACS patients as compared to conventional markers of myocardial damage.
Entities:
Keywords:
CK-MB; Mycradial ischemis; NT-proBNP; TnT; non elevated ST segment
Authors: Torbjørn Omland; James A de Lemos; David A Morrow; Elliot M Antman; Christopher P Cannon; Christian Hall; Eugene Braunwald Journal: Am J Cardiol Date: 2002-02-15 Impact factor: 2.778
Authors: E Braunwald; E M Antman; J W Beasley; R M Califf; M D Cheitlin; J S Hochman; R H Jones; D Kereiakes; J Kupersmith; T N Levin; C J Pepine; J W Schaeffer; E E Smith; D E Steward; P Theroux; J S Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094
Authors: Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley Journal: Circulation Date: 2003-12-08 Impact factor: 29.690
Authors: L Lorgis; M Zeller; G Dentan; P Sicard; P Buffet; I L'Huillier; J C Beer; M Vincent-Martin; H Makki; P Gambert; Y Cottin Journal: BMJ Date: 2009-05-06
Authors: Benjamin Lidgard; Leila Zelnickv; Amanda H Anderson; Harold Feldman; Alan Go; Jiang He; Mayank Kansal; Madhumita Jena Mohanty; Rupal Mehta; Michael G Shlipak; Elsayed Soliman; Matt R Weir; Nisha Bansal Journal: Kidney360 Date: 2022-03-02